Trim24 Limits the Ability of p53 to Function as a Tumor Suppressor

The tumor suppressor protein p53 has been nicknamed the “guardian of the genome” because it safeguards the DNA from long-term damage or stress by controlling the expression of numerous genes involved in DNA repair, cell division, and cell death. FMI investigators have now narrowed in on some of the mechanisms that control p53 target gene activation.

Trim24 Limits the Ability of p53 to Function as a Tumor Suppressor

Image Credit: Friedrich Miescher Institute for Biomedical Research

p53 aids in the prevention of tumor development by halting cells with mutated or damaged DNA from dividing. The protein functions as a transcription factor that can be quickly activated in response to different forms of cellular stress, resulting in the immediate activation of genes involved in DNA repair, cell division, and cell death.

Unlike most other transcription factors, p53 can attach closed chromatin, a tightly packed form of DNA and proteins that inhibit gene expression by blocking transcription factors’ access to the genome. However, it is unknown how p53 engages closed chromatin and opens it up to allow target genes to be activated.

Luke Isbel, a Schübeler lab postdoctoral fellow, and his co-workers evaluated how p53 attaches to DNA in mouse embryonic stem cells and human tissues. The protein binds tightly packed stretches of DNA in both the mouse and human genomes, but its potential to loosen chromatin and turn on genes is controlled by another protein known as Trim24.

Trim24 was discovered to be localized to p53 sites in closed chromatin by the investigators. In the absence of Trim24, p53 strongly activated approximately half of the 203 p53-regulated genes.

According to the investigators, the results indicate that Trim24 typically restricts p53 activity in closed chromatin. Because Trim24 levels are increased in breast cancer and other types of tumors, the researchers hypothesize that the protein may limit p53’s ability to function as a tumor suppressor in cancer cells.

Source:
Journal reference:

Isbel, L., et al. (2023). Readout of histone methylation by Trim24 locally restricts chromatin opening by p53. Nature Structural & Molecular Biology. doi.org/10.1038/s41594-023-01021-8.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of AZoLifeSciences.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Targeting Cancer with Nanoparticle-Delivered Gene Therapy